Proving the potency of XIAP as a major inhibitor of TRAIL-induced apoptosis in melanoma cells, its overexpression strongly diminished TRAM/TRAIL-induced apoptosis by 60–70%, as compared to mock-transfected cells (Fig. 8D). Here, XIAP is linked to melanoma.